Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1year: a systematic review and meta-analysis
- Citation:
- Lancet Oncol vol 20 (3) 361-370
- Year:
- 2019
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Meta-Analysis
- Data Sharing:
- Alliance-data-source,-external-user
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 8
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821
- Corr. Author:
- Authors:
- Everardo D Saad Pierre Squifflet Tomasz Burzykowski Emmanuel Quinaux Suzette Delaloge Dimitris Mavroudis Edith Perez Martine Piccart-Gebhart Bryan P Schneider Dennis Slamon Norman Wolmark Marc Buyse
- Networks:
- NY018, PR028
- Study
- Alliance-A151716
- Multiple Studies, or Legacy Studies in Alliance Study:
- NCCTG-N9831, NSABP B-31
- Phases:
- N/A, 3
- Keywords: